Dr Reddy's Laboratories share price closes at ₹1,175; rises 3.07% on September 17

Key Takeaways

• Dr Reddy's Laboratories gained ₹35 or 3.07% to finish at ₹1,175 after reaching an intraday high of ₹1,190. 
• The ₹1,175 close remained below its 50-day, 100-day and 200-day DMAs, with the longest-period average at ₹1,237.30. 
• At ₹1,175, the share was only ₹74 above its ₹1,101 52-week low, while one-year performance stood at -10.33%. 

Dr Reddy's Laboratories share price closed at ₹1,175 on September 17, gaining ₹35 or 3.07%. The stock opened at ₹1,140, the same rounded level as the previous close and the displayed session low. It subsequently reached ₹1,190 before giving back part of the advance. The resulting ₹50 high-low range left the final price ₹35 above the low and ₹15 below the day's peak. 

A little over 2.46 million shares changed hands, with volume at 2,463,807. Market capitalisation stood at ₹98,074 crore. The 52-week range was ₹1,101 to ₹1,415. The September 17 close therefore sat ₹74 above the annual low and ₹240 below the high, leaving the stock materially closer to the lower endpoint in rupee terms. 

All three displayed moving averages were above the final price. The 50-day DMA stood at ₹1,188.90, only ₹13.90 above the close. The 100-day DMA was ₹1,217.80 and the 200-day measure ₹1,237.30. Those longer averages exceeded the close by ₹42.80 and ₹62.30, respectively. 

Returns remained negative over each of the four periods shown. The one-month reading was -2.08%. Both the three-month and six-month returns were -7.98%, while the one-year figure was -10.33%. The 3.07% rise on September 17 therefore represented a positive daily move within a set of negative period returns. 

The price path also showed a clear difference between the opening and the close. From ₹1,140 at the start of the day, Dr Reddy's Laboratories added ₹35 by the finish after having traded another ₹15 higher intraday. Even after the gain, the share did not move above its ₹1,188.90 50-day DMA on a closing basis. The closing level was also only about ₹74 above the annual low and ₹62.30 below the 200-day DMA. These relatively modest distances, together with volume above 2.4 million shares, defined the September 17 session more clearly than the stock's much wider ₹314 annual trading span.